Evidence map›Paper›PMID 29931542›Full record

ArticleHeart and vessels2018

Inflammatory features, including symptoms, increased serum interleukin-6, and C-reactive protein, in IgG4-related vascular diseases.

Satomi Kasashima, Atsuhiro Kawashima, Fuminori Kasashima, Masamitsu Endo, Yasushi Matsumoto, Kengo Kawakami

Abstract read
PubMed Publisher
In one paragraph

Article in Heart and vessels, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Renal Involvement in Retroperitoneal Fibrosis: Prevalence, Impact and Management Challenges.International journal of nephrology and renovascular disease · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Satomi KasashimaDepartment of Clinical Laboratory Science, Kanazawa University, 5-11-80 Kodatsuno, Kanazawa, 920-0942, Japan. sato-kasa@staff.kanazawa-u.ac.jp.ORCID http://orcid.org/0000-0002-9158-9898
Atsuhiro KawashimaDepartment of Pathology, National Hospital Organization, Kanazawa Medical Center, Kanazawa, Japan.
Fuminori KasashimaDepartment of Cardiovascular Surgery, National Hospital Organization, Kanazawa Medical Center, Kanazawa, Japan.
Masamitsu EndoDepartment of Cardiovascular Surgery, National Hospital Organization, Kanazawa Medical Center, Kanazawa, Japan.
Yasushi MatsumotoDepartment of Cardiovascular Surgery, National Hospital Organization, Kanazawa Medical Center, Kanazawa, Japan.
Kengo KawakamiDepartment of Cardiovascular Surgery, National Hospital Organization, Kanazawa Medical Center, Kanazawa, Japan.
Kanazawa Medical Center · JPKanazawa University · JP

Funding

AUC for Scientific Research (C) (JSPS KAKENHI) 26462119
6 · The paper itself

Abstract

Immunoglobulin (IgG) 4-related diseases (IgG4-RDs) are fibro-inflammatory conditions characterized by tumorous swelling and serum IgG4 levels. Intrapelvic IgG4-RD has been subclassified according to the localization site and aortic shape as IgG4-related aortic aneurysms (IgG4-AAs), periaortitis (IgG4-PA), and retroperitoneal fibrosis (IgG4-RF). The IgG4-AA pathogenesis would involve interleukin (IL)-6 upregulation, and Th2-predominant and Treg-activated immune conditions. We characterized the features of intrapelvic IgG4-RD lesions, including presence of vascular lesions. The clinical, serological, and pathological features, including cytokines concerning Th1/2 and Treg (IL-4, IL-6, IL-10, IL-13, and interferon-gamma) of patients with IgG4-AAs (n = 24), IgG4-PA (n = 8), and IgG4-RF (n = 10) were retrospectively compared. Clinical symptoms, such as low-grade fever, abdominal/lumber pain, and anemia, were frequently detected in IgG4-AAs but rarely in IgG4-RF. Serum IL-6 and C-reactive protein (CRP) were significantly higher in IgG4-AAs and IgG4-PA than in IgG4-RF. Pathologically, IL-6+ cells were more frequently detected in IgG4-PA and IgG4-AAs than in IgG4-RF. There were no noteworthy differences in the clinical complications, white blood cell counts, serum IgE, and serum and immunopositive cells of other cytokines between the subgroups. Among IgG4-AAs and IgG4-PA, serum IL-6 and IL-6+ cells correlated with CRP, aortic diameter, and periaortic fibrosis. IgG4-AA and IgG4-PA, but not IgG4-RF, were characterized by "inflammatory" features, such as increased CRP and serum/pathological IL-6, and clinical inflammatory symptoms; thus, IgG4-AA and IgG4-PA belong to the same group as IgG4-related vascular disease. High levels of CRP and IL-6 would be hallmarks of IgG4-related vascular disease.

Indexed as

AdultAgedAged, 80 and overBiomarkersC-Reactive ProteinFemaleHumansImmunoglobulin GImmunohistochemistryInflammationInterleukin-6MaleMiddle AgedRetrospective StudiesVascular DiseasesBiomarkersC-Reactive ProteinImmunoglobulin GInterleukin-6Cytokine valanceIgG4-related aortic aneurysmIgG4-related periaortitisIgG4-related retroperitoneal fibrosisInflammatory abdominal aortic aneurysmInflammatory symptomsInterleukins

Identifiers

PMID29931542
OpenAlexW2808885813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.